Bar-Haim, IL
Avraham Bar-Haim, Ma'Alot IL
Patent application number | Description | Published |
---|---|---|
20110021993 | MINIATURE DISPOSABLE OR PARTIALLY REUSABLE DOSING PUMP - The invention is a dosing pump that can be worn on the body of a patient for subcutaneously delivering liquid with centi-micro liter accuracy to his/her body. The dosing pump comprises a pump unit, an internal control unit; and a reservoir containing the liquid. The pump unit comprises a pump block ( | 01-27-2011 |
Erez Bar-Haim, Yavne IL
Patent application number | Description | Published |
---|---|---|
20090136462 | TUMOR ASSOCIATED ANTIGEN PEPTIDES AND USE OF SAME AS ANTI-TUMOR VACCINES - The present invention relates to tumor associated antigen (TAA) peptides and to use of same, of polynucleotides encoding same and of cells presenting same as anti-tumor vaccines. More particularly, the present invention relates to tumor associated antigen peptides derived from Uroplakin Ia, Ib, II and III, Prostate specific antigen (PSA), Prostate acid phosphatase (PAP) and Prostate specific membrane antigen (PSMA), BA-46 (Lactadherin), Mucin (MUC-1), and Teratocarcinoma-derived growth factor (CRIPTO-1) and the use of same as anti-tumor vaccines to prevent or cure bladder, prostate, breast or other cancers, carcinomas in particular. Most particularly, the present invention relates to tumor associated antigen peptides which are presentable to the immune system by HLA-A2 molecules. | 05-28-2009 |
Erez Bar-Haim, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20100291127 | TUMOR ASSOCIATED ANTIGEN PEPTIDES AND USE OF SAME AS ANTI-TUMOR VACCINES - The present invention relates to tumor associated antigen (TAA) peptides and to use of same, of polynucleotides encoding same and of cells presenting same as anti-tumor vaccines. More particularly, the present invention relates to tumor associated antigen peptides derived from Uroplakin Ia, Ib, II and III, Prostate specific antigen (PSA), Prostate acid phosphatase (PAP) and Prostate specific membrane antigen (PSMA), BA-46 (Lactadherin), Mucin (MUC-1), and Teratocarcinoma-derived growth factor (CRIPTO-1) and the use of same as anti-tumor vaccines to prevent or cure bladder, prostate, breast or other cancers, carcinomas in particular. Most particularly, the present invention relates to tumor associated antigen peptides which are presentable to the immune system by HLA-A2 molecules. | 11-18-2010 |
Gil Bar-Haim, Nes Ziona IL
Patent application number | Description | Published |
---|---|---|
20140234771 | ELECTROSTATIC INK COMPOSITION - The present invention provides an electrostatic ink composition comprising a carrier liquid, a resin, a pigment and a conductive polymer. Method for producing the electrostatic ink composition and methods for printing the composition are also disclosed. | 08-21-2014 |
Gil Bar-Haim, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20110189606 | TREATED FLUOROPOLYMER PARTICLES, METHODS OF MAKING TREATED FLUOROPOLYMER PARTICLES, TONER COMPOSITIONS, AND METHODS OF MAKING TONER COMPOSITIONS - Toner compositions, treated fluoropolymer particles, methods of making treated fluoropolymer particles, and the like, are disclosed. | 08-04-2011 |
Gil Bar-Haim, Holon IL
Patent application number | Description | Published |
---|---|---|
20120287180 | POSITIVELY CHARGED INK COMPOSITION - Positively charged ink compositions, its use and method of making the same are disclosed. A disclosed example of the positively charged ink compositions includes a combination of a carrier liquid, basic pigment-loaded resin particles, a charge director and an acidic charge adjuvant. | 11-15-2012 |
20130016420 | DUAL COLOR ELECTRONICALLY ADDRESSABLE INKAANM Yeo; Jong-SoukAACI Yeonsu-guAACO KRAAGP Yeo; Jong-Souk Yeonsu-gu KRAANM Berson; IgalAACI LodAACO ILAAGP Berson; Igal Lod ILAANM Bar-Haim; GilAACI HolonAACO ILAAGP Bar-Haim; Gil Holon ILAANM Grinwald; YaronAACI MeitarAACO ILAAGP Grinwald; Yaron Meitar IL - A dual color electronically addressable ink includes a positively charged ink and a negatively charged ink. The positively charged ink includes a non-polar carrier fluid, pigment-loaded basic resin particles having a first color, and an acceptor charge adjuvant. The negatively charged ink includes the non-polar carrier fluid, pigment-loaded acidic resin particles having a second color that is different than the first color, and a donor charge adjuvant. The dual color electronically addressable ink also includes at least one charge director. | 01-17-2013 |
20130071690 | DUAL COLOR ELECTRONICALLY ADDRESSABLE INK - A dual color electronically addressable ink includes a non-polar carrier fluid; a first colorant of a first color; and a second colorant of a second color that is different than the first color. The first colorant includes a first particle core, and a first functional group attached to a surface of the particle core. The first functional group is capable of carrying a positive charge and is chosen from a base or a salt of the base. The second colorant includes a particle core, and a second functional group attached to a surface of the particle core. The second functional group is capable of carrying a negative charge and is chosen from an acid or a salt of the acid. The ink further includes an additive chosen from polyhydroxystearic amide salt, polyhydroxystearic acid, aromatic butyric acid, and combinations thereof. | 03-21-2013 |
20130224649 | LIQUID ELECTROPHOTOGRAPHIC INK - The present disclosure provides for liquid electrophotographic inks having charge stabilizers and associated methods. In one example, a liquid electrophotographic ink can comprise a carrier liquid, a resin, a pigment, a negative charge director, and a charge stabilizer having a reduction potential of 0.16 v to 3.0 v. | 08-29-2013 |
Gil Bar-Haim, Holon Na IL
Patent application number | Description | Published |
---|---|---|
20130323636 | ELECTROSTATIC INK COMPOSITION - The present disclosure is drawn to an electrostatic ink composition comprising: (a) a carrier liquid; (b) particles comprising: (i) a polymer having a melt flow rate of less than 60 g/10 minutes, (ii) a colorant, (c) a charge director, wherein the electrostatic ink composition excludes a positively charged organic molecule or an organic molecule capable of becoming a positively charged organic molecule during an electrostatic printing process. Also disclosed herein is a method of producing a electrostatic ink composition and a method of electrophotographic printing an electrostatic ink composition. | 12-05-2013 |
20140320576 | ELECTROSTATIC PRINTING - Described herein is a method for electrostatic printing comprising: (i) providing an ink composition comprising: a hydrocarbon carrier liquid and particles comprising a resin and a colorant, and wherein the ink composition contains less than 0.3 mg of charge director per g of solids in the ink composition; (ii) adding a charge director to the ink composition, such that the total amount of charge director in the ink composition is at least 0.6 mg per g of solids in the ink composition, and, (iii) within a predetermined time of adding the charge director, printing the ink onto a print medium in an electrostatic printing process, wherein the predetermined time is 90 minutes or less. Also described herein is a packaged ink composition, and method for producing it. | 10-30-2014 |
Roy Bar-Haim, Ramat Gan IL
Patent application number | Description | Published |
---|---|---|
20120203584 | SYSTEM AND METHOD FOR IDENTIFYING POTENTIAL CUSTOMERS - A system and method for identifying potential customers is provided. Information in a proprietary data repository of a company may be analyzed to thereby determine a first set of textual terms. Publicly available information related to the existing customer set may be analyzed to thereby determine a second set of textual terms. Terms in the first and second sets may be associated with scores. A customer profile may be generated based on the textual terms and associated scores. Potential customers may be identified based on the buyer profile. Other embodiments are described and claimed. | 08-09-2012 |
Shay Bar-Haim, Netanya IL
Patent application number | Description | Published |
---|---|---|
20090163537 | Thienopyridinone Compounds and Methods of Treatment - The invention relates to 5-HT receptor agonists and partial agonists. Novel thienopyridinone compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include Alzheimer's disease, cognition disorders, irritable bowel syndrome, nausea, emesis, vomiting, prokinesia, gastroesophageal reflux disease, nonulcer dyspepsia, depression, anxiety, urinary incontinence, migraine, arrhythmia, atrial fibrillation, ischemic stroke, gastritis, gastric emptying disorders, feeding disorders, gastrointestinal disorders, constipation, erectile dysfunction, and respiratory depression. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included. | 06-25-2009 |
20100113485 | Piperidinylamino-thieno[2,3-D] Pyrimidine Compounds - The invention relates to 5-HT receptor modulators, particularly 5-HT | 05-06-2010 |
20110082157 | Piperidinylamino-Thieno [2,3-D] Pyrimidine Compounds - The invention relates to 5-HT receptor antagonists. Novel piperidinylamino-thieno [2,3-d] pyrimidine compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include central nervous system disorders such as pulmonary arterial hypertension, migraine, hypertension, disorders of the gastrointestinal tract, restenosis, asthma, obstructive airway disease, prostatic hyperplasia and priapism, anxiety, depression, schizophrenia, neural injury and stroke. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also provided. | 04-07-2011 |
20110195953 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS - The invention generally relates to thienopyridinone 5-HT | 08-11-2011 |
Simona Bar-Haim, Beer Yaakov IL
Zvi Bar-Haim, Ihud IL
Patent application number | Description | Published |
---|---|---|
20120153927 | FAULT CURRENT LIMITER WITH SATURATED CORE - A three-phase current limiter ( | 06-21-2012 |
20120154966 | FAULT CURRENT LIMITERS (FCL) WITH THE CORES SATURATED BY NON-SUPERCONDUCTING COILS - A current limiting device ( | 06-21-2012 |
Zvi Bar-Haim, En Harod Ihud IL
Patent application number | Description | Published |
---|---|---|
20090021875 | FAULT CURRENT LIMITERS (FCL) WITH THE CORES SATURATED BY SUPERCONDUCTING COILS - A current limiting device ( | 01-22-2009 |